Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 3 Esophageal Neoplasms 3 Lymphatic Metastasis 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Recurrence 1 Pathologic Complete Response 1 Neoplasm Metastasis 1 Melanoma 1 Carcinoma, Squamous Cell 1 Breast Neoplasms 1

Interventions

Nivolumab 23 pembrolizumab 19 Ipilimumab 13 toripalimab 12 Temozolomide 11 Biopsy 8 Dacarbazine 7 Blood Specimen Collection 6 trametinib 5 dabrafenib 5 camrelizumab 5 atezolizumab 5 Gene Expression Profiling 5 Cyclophosphamide 5 Chemotherapy, Adjuvant 5 fludarabine 4 durvalumab 4 binimetinib 4 aldesleukin 4 Injections 4 tislelizumab 3 palbociclib 3 encorafenib 3 apatinib 3 Sorafenib 3 Introns 3 Interleukin-2 3 Drug Therapy 3 Cisplatin 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Melanoma × TP protocol × Clear all

NCT00779714 2008-10-24

ChemoSensMM

University of Wuerzburg

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡